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Conclusion. These data demonstrate considerable variabil-A prospective cohort study of incident maintenance dialysis in
ity in patient management across pediatric centers. Prospectivechildren: An NAPRTC Study.
studies are needed to determine the optimum adequacy of careBackground. Prior studies of dialysis practices and outcomes
among children on dialysis and to identify populations at risk.have included children with varied duration of end-stage renal
disease (ESRD). This study evaluated dialysis characteristics,
complications, practices, and outcomes in an incident pediatric
cohort. The North American Pediatric Renal Transplant Co-Methods. The cohort was limited to 1992 subjects enrolled in
operative Study (NAPRTCS) is an ongoing voluntarythe North American Pediatric Renal Transplant Cooperative
research initiative started in 1987 to study renal trans-Study registry, starting hemodialysis (HD) or peritoneal dial-
ysis (PD) between 1992 and 1998, without prior dialysis or plantation in children and adolescents. In 1992, the study
transplantation. expanded to include pediatric patients receiving main-
Results. At dialysis initiation, the median glomerular filtra- tenance hemodialysis (HD) or peritoneal dialysis (PD)tion rate (GFR; Schwartz formula) was 6 to 11 mL/min/1.73 m2,
therapy at participating NAPRTCS centers. The NAPRTCSand 90th percentile was 14 to 25 mL/min/1.73 m2. GFR was not
registry captures the vast majority of young children withassociated with age or race. PD was used in 97% of infants, 70
to 80% of children and 59% of adolescents. Blacks were sig- end-stage renal disease (ESRD) in North America.
nificantly less likely to be started on PD than whites. Twenty Three prior publications from the dialysis component
percent of patients switched dialysis modality, largely due to of the NAPRTCS registry described the treatment prac-
infection, inadequate access or family choice. Younger children
tices and complications among the aggregate dialysis pop-received HD almost exclusively through percutaneous cathe-
ulation [1–3]. That is, each dialysis course was consideredters, while 57% of children more than six years old were dia-
a discrete and independent unit of observation, whetherlyzed with fistula or graft after six months on HD. The preva-
lence of anemia (Hct 33%) still exceeded 40% after six initiated for new-onset ESRD, transplant allograft fail-
months of dialysis. The median interval to transplantation was ure or a change in dialysis modality (that is, between
1.4 years, and was significantly greater in non-white, young, HD and PD).and female patients. Mortality rates (deaths/1000 patient-
The concurrent United States Renal Data Systemyears) varied with age, from 13.6 in infants to 2.2 in adolescents.
(USRDS) Annual Data Reports also described pediatric
ESRD; however, these summaries admixed the dialysis
1 The North American Pediatric Renal Transplant Cooperative Study and transplantation populations and many of the analy-
(NAPRTCS) is a voluntary collaborative effort comprising over 150 ses combined infants through adolescents 19 years of
pediatric renal disease treatment centers in the United States, Canada,
age [4]. USRDS descriptions of dialysis modality wereMexico and Costa Rica. It is supported by major, unrestricted educa-
tional grants from Novartis, AMGEN, and Genentech. Participating limited to the treatment modality at two years following
NAPRTCS Centers are listed in the most recent NAPRTCS Annual ESRD onset, when most pediatric patients already had
Report [Seikaly M, Ho PL, Emmet L, Tejani A: The 12th Annual Re-
a functioning renal allograft. Similarly, the USRDS de-port of the North American Pediatric Renal Transplant Cooperative
Study (NAPRTCS): Renal Transplantation from 1987 through 1998. scriptions of pediatric transplantation rates included pa-
Pediatr Transplant 5:215–231, 2001]. tients who were transplanted without receiving prior di-
alysis and, therefore, do not provide information on theKey words: dialysis, children, end-stage renal disease, kidney failure in
children, hemodialysis, adolescents and renal disease, peritoneal dialysis. duration of maintenance dialysis among children requir-
ing dialysis.Received for publication April 11, 2002
More recently, the first pediatric report of the ESRDand in revised form August 22, 2002
Accepted for publication October 8, 2002 Clinical Performance Measures Project was published
[5]. The report captured 89% of adolescents receiving in- 2003 by the International Society of Nephrology
744
Leonard et al: Cohort study of dialysis in children 745
Table 1. Patient characteristics among incident pediatriccenter hemodialysis in December 1999; data on younger
dialysis patients
children and children on PD have not been collected.
N %The median duration of dialysis at the time of data collec-
tion was 1.3 years and the mean duration was 2.9 years, Total 1992 100.0
reflecting the varied ESRD experiences of this cross- Age at dialysis initiation
12 mo 237 11.9sectional population.
12–23 mo 72 3.6In contrast, the objective of the present study was to
2–5 yr 219 11.0
define a pediatric cohort of incident maintenance dialysis 6–12 yr 634 31.8
13–17 yr 738 37.0patients, with no prior history of dialysis or transplanta-
17 yr 92 4.6tion, in order to examine patient characteristics at the
Race
time of dialysis initiation, and the cumulative dialysis White 1012 50.8
experience (including dialysis modalities, dialysis access Black 447 22.4
Hispanic 395 19.8characteristics, complications, medications), and trans-
Other 138 6.9plantation and mortality rates. Gender
Female 906 45.5
Male 1086 54.5
METHODS
The NAPRTCS consists of a Clinical Coordinating
Center, a Data Coordinating Center (DCC) and over 150
RESULTSparticipating pediatric nephrology centers in the United
States, Canada, Mexico and Costa Rico. The data col- Patient registration
lected by each center are sent on a voluntary basis to the Through December 1998, the NAPRTCS registry com-
DCC. Patients are registered when they develop chronic
piled data on a total of 3748 dialysis patients. Among
renal insufficiency (CRI) or ESRD. Patients are included
these patients, dialysis initiation forms were submitted
in the dialysis arm of the registry if less than 21 years of
for 4930 independent courses of HD or PD. A total ofage at the time of initiation of dialysis. A dialysis mod-
736 patients initiated dialysis prior to January 1992. Sinceality initiation form is completed after 30 days of mainte-
then, there has been a stable rate of enrollment of chil-nance dialysis. The NAPRTCS dialysis modality initia-
dren started on dialysis, with 433 to 497 new patientstion form documents the serum creatinine concentration
each year. Of the 3012 patients who enrolled after Janu-and length/height immediately prior to dialysis initiation.
ary 1992, 1992 (66%) had not received any form of main-These variables were used to estimate glomerular filtra-
tenance renal replacement therapy prior to NAPRTCStion rate (GFR; mL/min/1.73 m2), according to the method
enrollment. These 1992 children, representing 119 differ-of Schwartz et al [6]. Information regarding dialysis sta-
ent NAPRTCS centers, comprise the incident dialysistus, growth, medications, complications, hospitalizations
cohort reported here.and transplant evaluation is updated six months after
dialysis initiation and every six months thereafter. Addi- Patient characteristics
tional information is provided in the event of an access
The characteristics of these incident patients are sum-revision, dialysis modality termination, renal transplanta-
marized in Table 1. Infants less than twelve months oftion or death.
age made up 11.9% of patients initiating maintenanceThe NAPRTCS dialysis registry was started in January
dialysis at NAPRTCS centers, while adolescents greater1992. The cohort for this report was defined as those
than 17 years of age comprised only 4.6% of dialysis reg-children and adolescents starting maintenance dialysis
istrants. Overall, 55% of the incident dialysis patientsbetween January 1, 1992 and December 30, 1998. Sub-
were male. This slight male predominance was due to thejects were limited to incident ESRD dialysis patients;
greater incidence of congenital disorders, including renalthat is, those who had not received maintenance dial-
dysplasia and obstructive uropathy in males. Accord-ysis or renal transplantation prior to enrollment in the
ingly, the male predominance was most apparent in theNAPRTCS dialysis registry.
youngest age groups where males accounted for 65% ofChi-squared tests were performed for comparison of
those less than 12 months, 58% of those 12 to 24 monthsbinary and categorical endpoints, and t tests for compari-
and 55% of those two to five years of age.son of continuous variables. Wilcoxon rank-sum was used
Table 2 describes the primary etiology of ESRD amongto compare nonparametric continuous variables. Kaplan-
these incident maintenance dialysis patients. The mostMeier product-limit estimates of transplantation rates
common diagnoses were renal aplasia/hypoplasia/dys-and changes in dialysis modalities were compared using
plasia (14%), focal segmental glomerulosclerosis (FSGS)the log-rank test. Relative rates (RR) were derived from
(14%) and obstructive uropathy (12%). When stratifiedCox proportional hazards regression models, adjusted
for selected patient characteristics. according to race, the distributions of renal diagnoses
Leonard et al: Cohort study of dialysis in children746
Table 2. Etiology of ESRD among incident pediatric dialysis patients
White Black Age 12 years
% of
Diagnosis N Total %
Aplastic/hypoplastic/dysplastic kidneys 283 14.2 55.8 17.0 77.4
Focal segmental glomerulosclerosis 281 14.1 40.9 40.2 48.4
Obstructive uropathy 241 12.1 55.6 17.4 67.2
Systemic immunologic disease 163 8.2 41.1 27.6 30.7
Reflux nephropathy 76 3.8 68.4 5.3 46.1
Chronic glomerulonephritis 66 3.3 37.9 25.8 34.8
Polycystic kidney disease 64 3.2 62.5 15.6 82.8
Hemolytic uremic syndrome 50 2.5 80.0 12.0 76.0
Congenital nephrotic syndrome 49 2.5 61.2 16.3 87.8
Idiopathic crescentic glomerulonephritis 47 2.4 42.6 21.3 55.3
Familial nephritis 46 2.3 43.5 19.6 17.4
Medullary cystic disease/juvenile nephronophthisis 42 2.1 71.4 21.4 47.6
Membranoproliferative glomerulonephritis Type I 40 2.0 40.0 22.5 47.5
Syndrome of agenesis of abdominal musculature 38 1.9 68.4 15.8 86.8
Pyelonephritis/interstitial nephritis 35 1.8 65.7 17.1 54.3
Renal infarct 34 1.7 70.6 17.6 91.2
Cystinosis 29 1.5 79.3 6.9 72.4
Wilm’s tumor 16 0.8 50.0 37.5 81.3
Membranoproliferative glomerulonephritis Type II 15 0.8 80.0 6.7 53.3
Membranous nephropathy 12 0.6 25.0 58.3 16.7
Oxalosis 10 0.5 70.0 0.0 80.0
Drash syndrome 9 0.5 66.7 11.1 88.9
Sickle cell nephropathy 6 0.3 0.0 100 16.7
Diabetic glomerulonephritis 4 0.2 0.0 100 0.0
Other 183 9.2 53.0 17.5 65.6
Unknown 153 7.7 23.5 26.1 43.1
Total 1992 100.0 50.8 22.4 58.4
The racial and age distributions are provided for each diagnosis.
differed substantially. Among blacks, FSGS accounted differences according to age or race. When comparing
for 25% of all patients and 33% of those greater than the distributions of GFRs within each age group, the data
12 years of age. FSGS was twice as common as any other were skewed with a small number of patients with GFRs
diagnosis among black children on dialysis. The second approaching the normal range. A subgroup analysis of the
most common diagnosis among all blacks was renal dys- etiology of renal disease among the children with GFR
plasia (11%), and among black patients greater than 12 greater than 25 mL/min/1.73 m2 at the time of dialysis
years of age was systemic immunologic disease (14%). initiation revealed that the majority of infants within this
Among whites, FSGS accounted for only 11% of all subgroup had congenital nephrotic syndrome or Drash
patients, and 12% of adolescents. Renal dysplasia is the syndrome. These children underwent nephrectomy at the
most common cause of ESRD among all whites (16%). time of dialysis initiation. Among older children with
Consistent with the differences in the etiology of ESRD GFR25 mL/min/1.73 m2, the majority had focal segmen-
between whites and blacks, 64% of whites were less than tal glomerulosclerosis or systemic lupus erythematosis.
12 years of age at the time of dialysis initiation, compared
to 43% of blacks. The distribution of primary renal diag- Dialysis modality at initiation: Hemodialysis or
noses among Hispanic patients was similar to that for peritoneal dialysis
white patients.
Among these incident pediatric patients, 70% were
started on PD and the remaining 30% were started onRenal function at the time of dialysis initiation
HD. As shown in Figure 2, the initial dialysis modalityFigure 1 demonstrates the variability in estimated GFR
selection differed significantly according to age and race.at initiation of dialysis among pediatric incident ESRD
Among the infants and toddlers less than two years ofpatients. Among infants, the median estimated GFR was
age, 96% were started on PD and the remainder was6 mL/min/1.73 m2, with a 90th percentile of 13 mL/min/
treated with HD. Among the adolescents, 59% were1.73 m2. Among children and adolescents greater than
started on PD. In addition, whites were more likely thantwelve months of age, the median estimated GFR at
blacks to be started on PD compared with HD; thisdialysis initiation varied from 8 to 11 mL/min/1.73 m2 in
difference was statistically significant (P  0.05) withinthe various age groups, with the 90th percentile ranging
from 14 to 25 mL/min/1.73 m2. There were no significant all but the youngest age group.
Leonard et al: Cohort study of dialysis in children 747
Fig. 1. Estimated glomerular filtration rate (GFR) at dialysis initiation according to age and race. (A) White. (B) Black. The horizontal line
denotes the median GFR, the shaded region represents the 25th and 75th percentiles, and the brackets indicate the 10th and 90th percentiles.
Renal transplantation rates among maintenance
dialysis patients
Among incident dialysis patients the median total du-
ration of maintenance dialysis (HD and/or PD) prior to
first transplantation was 1.4 years. Overall, 37% were
transplanted within one year following dialysis initiation.
The time to transplantation was significantly shorter
among children receiving living related donor allografts,
compared with cadaveric allografts (P  0.0001). Figure
3 summarizes the time to transplantation according to
recipient gender, race, age and dialysis modality at dial-
ysis initiation. Dialysis terminations caused by other rea-Fig. 2. Percentage of incident dialysis patients started on peritoneal
dialysis (vs. hemodialysis) at dialysis initiation, according to age and sons including death were regarded as censored.
race. Symbols are: ( ) white; () black; ( ) Hispanic.
Figure 3C indicates that patients in the youngest pa-
tient groups (2 years of age) received maintenance
dialysis for a longer interval prior to transplantation than
patients in the older age groups (2–5, 6 to 12, and 12).Dialysis modality termination
The median time till transplantation for children less
As of December 31, 1998, dialysis modality termina- than two years of age was 2.1 years compared to less than
tion forms had been filed for 1385 (70%) of the incident 1.4 years among the older age groups. Sixteen percent of
dialysis patients. In most cases, renal transplantation these youngest dialysis patients were transplanted within
(68%) or a change in dialysis modality (20%) accounted one year following dialysis initiation, compared to ap-
for dialysis termination. Less common explanations in- proximately 40% of patients in older age groups. Among
cluded death (3%) or return of native kidney function the children starting dialysis at less than two years of
age, the mean ( SD) weight and height at the time of(5%).
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Fig. 3. Time to transplantation among incident maintenance dialysis patients. (A) Initial dialysis modality. (B) Gender. (C ) Age at dialysis
initiation. (D) Race.
Table 4. Multivariable Cox proportional hazard analysis ofTable 3. Duration of maintenance dialysis prior to transplantation,
by selected characteristics transplantation rates
Characteristic Relative risk P valueProportion (%)
Median duration transplanted
ModalityCharacteristic years at 1 year P value
HD vs. PD 1.7 0.043
GenderInitial modality
Peritoneal dialysis 1.4 34 0.030 Male vs. Female 1.25 0.013
AgeHemodialysis 1.2 44
Gender 2–5 vs. 2 yr 2.0 0.0001
6–12 vs. 2 yr 2.1 0.0001Male 1.4 37 0.113
Female 1.4 36 12 vs. 2 yr 1.9 0.0001
RaceAge
0–1 2.1 16 0.0001 White vs. Black 1.7 0.0001
White vs. Hispanic 1.5 0.00012–5 1.3 39
6–12 1.2 43 White vs. Other 1.3 0.037
12 1.4 39
Race
White 1.2 42 0.0001
Black 1.7 27
Hispanic 1.7 31 the proportion transplanted at one year after dialysis
Other 1.4 38 initiation, and P values of the log rank test of the sub-
groups.
To assess the variables shown in Figure 3, Cox regres-
sion was used to adjust for covariates. Table 4 summa-eventual transplantation was 11.7  2.7 kg and 81 
8.8 cm, respectively. There were no differences in the rizes the adjusted effects of dialysis modality, gender,
race, and age group at dialysis initiation. The rate oftransplantation rates across the older age groups (Fig.
3C). Table 3 summarizes the median duration of dialysis, transplantation was decreased for non-white patients,
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Fig. 4. Distribution of transplantation status
at each interval following initiation of mainte-
nance dialysis therapy among incident dialysis
patients.
for patients less than two year of age at dialysis initiation, polycystic kidney disease and renal infarct. Of note, 12%
and 22% of patients initiating dialysis for FSGS or sys-for females, and for patients started on PD at dialysis
temic immunologic disease, respectively, were classifiedinitiation. The transplantation rates for black patients
as “not considered transplant candidate” after six monthswere not significantly different from patients with His-
on dialysis.panic and other ethnic backgrounds. The rates of trans-
Figure 4 depicts patient classification as either a trans-plantation among all patients greater than two years of
plant candidate (on waiting list or transplant work-up inage at dialysis initiation were similar. Finally, a compari-
progress), non-candidate, or transplant recipient overson of era (1992 to 1995 vs. 1996 to 1998) shows no evi-
time. Figure 4 demonstrates the increasing proportiondence that transplantation rates have changed over time.
of patients transplanted, moved onto the cadaveric wait-Thus, children are not transitioning from dialysis to
list or undergoing evaluation for a transplant as the total
transplantation more quickly overall, and there is no evi- number of patients remaining on dialysis decreases over
dence that rates in the youngest children have increased. time. Among the 107 patients still on dialysis 36 months
The dialysis registry collects information every six after initiation, 23% were not considered candidates for
months regarding the status of the transplant evaluation. transplantation due to medical reasons, and another 23%
The majority of patients were either on the cadaveric due to family or patient preference.
donor waiting list (10%) or were classified as having a
Change in dialysis modalitytransplant work-up in progress one month after dialysis
initiation (48%). However, significant proportions were Among the 388 incident HD patients that terminated
HD, 82 (21%) transitioned to PD, while 194 (20%) ofnot considered candidates for transplantation, either due
the 997 incident PD patients transitioned to HD. Mostto medical reasons or patient preference. The youngest
of the modality changes from HD to PD occurred withinchildren were significantly more likely to be classified as
the first few months on treatment; very few patients‘not a transplant candidate’ on the day 30 Dialysis Ini-
changed from HD to PD after that interval. In contrast,tiation Form: 75% of infants and toddlers (age less than
patients on PD demonstrated a slow and steady increase2 years) and 36% of older children were classified as
in PD terminations over time as they transitioned tonon-candidates (P  0.001). Among patients classified
HD. The most common reasons for a change in dialysis
as “not considered transplant candidate” at six months modality were excessive infection, patient/family choice,
after dialysis initiation, the underlying renal diagnoses or access failure. As expected, these reasons differed ac-
varied substantially. The proportion of subjects classified cording to the original dialysis modality, as summarized
as “not considered transplant candidate” within each in Figure 5. Among patients initially on HD, the most
diagnostic category was examined at six months follow- common reason for a change to PD was patient/family
ing dialysis initiation. Overall, the highest proportions choice or access failure, while the most common reason
(greater than 25%) occurred among the following diag- for a modality change from PD to HD was excessive
infections.noses: Wilm’s tumor, congenital nephrotic syndrome,
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Fig. 5. Reasons for a change in dialysis mod-
ality among incident dialysis patients. Symbols
are: () transition from PD to HD; ( ) transi-
tion from HD to PD.
Fig. 6. Peritoneal dialysis modality as a function of patient age at
initiation among incident PD patients. Symbols are: () IPD; ( ) APD;
() CAPD.
Peritoneal dialysis modality, access and complications Fig. 7. Number of hemodialysis treatments per week at day 30 after
HD initiation, according to age. Symbols are: () 3 treatments/week;At initiation of PD, as well as throughout PD follow-
( ) 3 treatments/week; () 3 treatments/week.up, automated PD (APD), was the favored modality and
was used by nearly 70% of patients. The use of APD,
continuous ambulatory PD (CAPD) and intermittent
PD (IPD) at initiation of dialysis differed significantly Hemodialysis frequency, access and complications
(P  0.001) as a function of patient age (Fig. 6): there
Figure 7 demonstrates the variation in the weekly fre-was greater utilization of IPD, and less of CAPD among
quency of HD according to age. A significant portion ofthe infants and toddlers (P  0.001). Dialysis modality
the infants and toddlers (5 of 11) received treatmentswas likely related to center preferences: most centers
more than three times per week, while none were treatedreported zero or one young child on CAPD, while 15%
once or twice per week. The use of greater treatment fre-of the infants and toddlers on CAPD were from a single
quency may relate to center preferences: nineteen pa-center.
tients were dialyzed more than three times per week;Among 1404 incident PD catheters, there were 629
three centers cared for 13 (68%) of these patients.(45%) PD access revisions. Among the 326 revisions where
In contrast, 11% of children greater than age six yearsa reason was specified, the most common cause was
were dialyzed one to two times per week. Although thecatheter malfunction, which accounted for 50% of revi-
renal function at dialysis initiation in patients who weresions, most occurring in the first six months following
dialyzed only once or twice per week was significantlyPD initiation. The remaining revisions were largely due
to exit-site or tunnel infections (15%) or peritonitis (21%). greater than those who were dialyzed more frequently
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Table 5. Hemodialysis access in use on day 30 and at 6 months
External percutaneous catheter Internal AV graft
Age at External Internal
initiation Subclavian Jugular Femoral AV shunt AV fistula PTFE Bovine Autologous
Patients initially on HD, N  584
0–2 6 4 1 0 0 0 0 0
2–5 27 12 3 1 0 0 0 0
6–12 122 33 7 0 12 13 1 0
12 160 50 19 5 60 47 0 1
Patients still on HD after six months, N  276
0–2 3 2 0 0 0 0 0 0
2–5 10 5 0 0 1 0 0 0
6–12 37 7 0 0 20 14 1 0
12 50 11 2 2 64 44 1 1
(P .0001), the difference may not be clinically significant pertensive medication. However, previous NAPRTCS
Annual Reports describing aggregate dialysis courses(median calculated GFR 10.7 vs. 8.9 mL/min/1.73 m2).
Moreover, the dialysis schedule varied over time among suggested that patients on HD required a greater number
of antihypertensive agents than those on PD. This maybethe 64 HD patients dialyzed once or twice per week on
day 30 after dialysis initiation. Nine (14%) maintained related to differences in age distributions, underlying
renal disease and race. Figure 8 demonstrates the rela-such a schedule at 12 months, 11 (17%) adopted a three
times per week schedule, 11 (17%) switched to PD, 1 tionship between the number of antihypertensive medi-
cations, dialysis modality and patient race at 30 daysregained native kidney function, 1 died, and the remain-
der were transplanted. post-initiation of incident dialysis course. Unadjusted
analyses, stratified on race, show that patients on HDTable 5 provides data on HD access locations and
devices on Day 30 after dialysis initiation in the 584 are treated with a significantly greater number of anti-
hypertensive medications, compared to PD (whites, Pincident HD patients. External percutaneous catheters
were used in 53 of the 54 children less than six years of 0.04; blacks, P  0.03). Stratified on dialysis modality,
blacks receive significantly more antihypertensive medi-age and in 86% of children ages six through 12 years of
age. Most percutaneous catheters were at the subclavian cations than whites (HD, P  0.02; PD, P  0.04).
Previous NAPRTCS reports also state that the num-site. Even among the children greater than 12 years of
age, only 18% had an arteriovenous (AV) fistula and ber of prescribed antihypertensive medications at dial-
ysis initiation (HD or PD) was greater than the number14% had an AV graft on HD day 30. However, the Day
30 access data forms only collect information on the at the 12-month follow-up. This decreased antihyperten-
sive utilization over time on dialysis may represent thesingle access in use on Day 30; therefore, these data do
not include information on maturing or malfunctioning discontinuation of antihypertensive therapy in patients
on dialysis, or the selective termination of dialysis amongAV grafts or fistulas. Consequently, we examined dial-
ysis access types in use six months after HD initiation patients with greater antihypertensive use (such as, for
transplantation). Therefore, antihypertensive use was(summarized in Table 5). Younger children continue to
receive HD almost exclusively through percutaneous compared at one and 12 months on dialysis among those
551 patients with at least 12 months of dialysis follow-upcatheters; however, 33% and 24% of patients greater
than six years of age were dialyzed via AV fistula or and complete medication data at 30 days and 12 months.
Within this subgroup, the distribution of the number ofgraft, respectively, after six months on dialysis. Finally,
there is no evidence of center effects for the use of AV antihypertensive agents at day 30 was nearly identical
to that seen at 12 months.fistula or grafts; the number of patients with fistulas and
grafts is proportional to the total number of HD patients Phosphate binders and vitamin D. Among both HD
and PD patients, greater than 95% received calciumfor each center.
Overall, there were 919 access revisions reported supplementation throughout dialysis follow-up, approxi-
mately 75% as calcium carbonate, 15% as calcium ace-among the 584 original HD accesses described above.
The most common reasons for an access revision were tate and the remainder as other calcium supplements.
Among PD patients, 79% and 83% were receiving oralclotting (29%), malfunction (21%), creation of a more
permanent access (31%) or infection (14%). vitamin D at one and 12 months post-initiation of dial-
ysis, respectively. One and 4% percent received intrave-
Medications nous vitamin D (none was on parenteral nutrition), at
one and six months, respectively. Among HD patients,Antihypertensive medications. Overall, approximately
50% of children on dialysis require at least one antihy- a slightly greater percentage received vitamin D therapy
Leonard et al: Cohort study of dialysis in children752
Fig. 8. Number of antihypertensive medications among HD and PD
patients on dialysis at day 30, according to race. Symbols are: () no
antihypertensive; ( ) 1 antihypertensive; ( ) 2 antihypertensives; ( ) 3
antihypertensives; () 4 antihypertensives.
Fig. 9. Distribution of hematocrit (Hct) levels among patients on HD
at six months, according to timing of the erythropoietin initiation. Sym-at one and 12 months (86% and 90%, respectively).
bols are: () Hct 27%; ( ) Hct 27 to 30%; ( ) Hct 31 to 34%; ( )
During HD follow-up, the percentage of vitamin D ad- Hct 35%.
ministered via the intravenous route increased from 31%
at one month to 51% at 24 months. Until recently, the
registry did not collect the absolute intact-parathyroid levels at six months, according to the timing of EPO
hormone (PTH) levels and, therefore, it is not possible initiation, is shown in Figure 9. Postponed initiation of
to compare dialysis modalities and treatment strategies EPO treatment was associated with a significantly greater
in terms of the management of renal osteodystrophy or prevalence of anemia after six months of dialysis.
the risk of adynamic bone disease. The 1997 National Kidney Foundation-Dialysis Out-
comes Quality Initiative (DOQI) guidelines for the treat-Iron supplementation and erythropoietin use
ment of anemia recommend a target Hct of 33% to 36%
One month after dialysis initiation, a total of 72% of for EPO therapy [7]. To determine if dissemination of
PD and 78% of HD patients were receiving iron therapy. the DOQI guidelines has impacted the management of
Only 1% of PD patients received intravenous iron; the anemia in children with ESRD, we examined the preva-
remaining patients were prescribed oral supplements. In lence of anemia, EPO therapy and iron therapy among
contrast, 11% of HD patients received intravenous iron. patients at the initiation of dialysis and after six months
By six months after dialysis initiation, 3% and 81% of of follow-up, according to calendar year. For these analy-
PD patients were receiving intravenous or oral iron sup- ses, anemia was defined as an Hct of less than 33%.
plementation, respectively, while 23% and 73% of HD Figure 10 demonstrates that EPO and iron were used in
patients received intravenous or oral iron supplementa- a greater proportion of patients at six months of dialysis
tion, respectively. Therefore, children on HD were more compared to day 30. This is associated with a lower
likely to be on iron therapy overall, particularly intrave- prevalence of anemia at six months compared to day 30;
nous iron supplementation. nonetheless, the prevalence of anemia is 40 to 60%
The frequency of erythropoietin (EPO) use was ini- among patients on dialysis after six months. There also
tially less for PD (83%) compared to HD patients (90%); is evidence that the percentage of patients treated with
however, after two years of dialysis therapy, EPO use EPO and iron has increased over the seven years of the
was similar (94% for both). The route and frequency of registry. Although the prevalence of anemia appeared
EPO administration varied according to dialysis mod- to be decreasing from 1992 to 1996, the prevalence in-
ality. Most PD patients on EPO received subcutaneous creased slightly in 1997 to 1998. Despite the increased use
administration (95%), few patients received intraperito- of iron and EPO over the last seven years, a substantial
neal EPO (1 to 3%) or intravenous EPO (2 to 4%). In portion of subjects did not attain the recommended Hct.
contrast, most HD patients were treated intravenously
Dialysis adequacy(92%). EPO dosing, expressed as units per kg per week,
was higher in HD patients than PD patients. The dosing NAPRTCS data collection forms do not collect infor-
routes were comparable across race and gender. mation on dialysis dose.
To assess the relationships between the prevalence of
Mortalityanemia and administration of EPO, EPO use was as-
sessed in the 1382 patients still maintained on dialysis Table 6 summarizes mortality rates among the incident
cohort. These unadjusted rates are highest among infantsafter six months. The distribution of hematocrit (Hct)
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Fig. 10. Prevalence of anemia (), iron ther-
apy () and EPO () use at (A) day 30 and
(B) six months among incident dialysis pa-
tients according to calendar year of dialysis
initiation.
Table 6. Mortality rates among incident maintenance dialysisless than 12 months, compared with older children (P 
patients according to age at dialysis initiation
0.001).
Deaths per 100 dialysis patient-years
Total White Black Hispanics
DISCUSSION
Age at dialysis initiation
To our knowledge, these data are the first to describe 0–2 months 15.7 16.8 9.7 15.2
2–12 months 11.5 9.7 30.3 10.0dialysis treatment patterns among a large incident cohort
12–24 months 8.2 8.0 0 12.0of children. Because NAPRTCS captures the vast major-
2–5 6.1 6.1 4.2 8.0
ity of young children on dialysis in North America, these 6–12 3.5 3.3 5.9 1.9
12 2.2 1.8 3.2 1.1data provide a largely unbiased assessment of the treat-
ment choices and experiences in these children cared
for by pediatric nephrologists. These data raise many
questions regarding the optimal delivery of ESRD care
differences between children and adults. Children withto these children.
ESRD have special needs and requirements that impactThe overall age distribution is consistent with USRDS
dialysis modality choice [8, 9]. PD is especially well suitedreports that ESRD incidence increases substantially with
for the younger age groups because it avoids the manyincreasing age among the pediatric population [4]. The
difficulties associated with the maintenance of vascularUSRDS report combined children in the 0 to 4 years of
access in children and minimizes the need for severe fluidage group, and therefore, did not distinguish infants from
and dietary restrictions. In older children, PD facilitatestoddlers and young children. In contrast, NAPRTCS
optimal school attendance and may foster independence.data demonstrated a greater proportion of infants (12
In contrast, the USRDS reports that less than 15% ofmonths of age) among young children. This is due to con-
adult dialysis patients are treated with PD; the vast ma-genital renal disease and its associated early-onset ESRD.
jority receives in-center HD [4]. Similarly, among pa-The relatively fewer patients enrolled in NAPRTCS
tients on PD, the types of PD differ according to treat-among the oldest age group (greater than 17 years) pre-
ment facility; 28% of teenagers in the NAPRTCS registrysumably reflects increased utilization of adult health care
were treated with APD while greater than 90% of youngcenters among adolescents. Furth et al recently reported
adults on PD were treated with CAPD [4].that dialysis centers that primary treat adults serve ap-
Although PD is widely thought to be the preferredproximately one third of the pediatric ESRD population,
dialysis modality for children, a recent study of racialand that it is predominantly adolescents that are treated
differences in dialysis modality choice reported that blackin these centers [8].
children were significantly more likely than white chil-The analysis of renal function at the initiation of dial-
dren to receive HD than PD, after adjusting for patientysis demonstrates significant variation in estimated GFR.
and facility characteristics [10]. The data presented hereHowever, these descriptions are limited by the inaccura-
demonstrate that similar racial patterns occur among child-cies of the Schwartz formula for GFR, particularly in
ren treated at pediatric centers. Another study demon-children with edema and poor nutritional status [6]. Pro-
strated that children receiving care at dialysis facilitiesspective studies are needed to better describe patterns of
that largely treat adults are more likely to receive HDdialysis initiation and the impact on growth, nutritional
than PD [8]. Among the centers with the greatest propor-status, infections, hospitalizations and the time to trans-
tion of adult patients, only 41% of children were treatedplantation.
The analyses of dialysis modality highlight substantial with PD. The NAPRTCS registry does not collect data
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on socioeconomic status or patient compliance; there- A greater dialysis dose may affect growth directly through
improvements in hormonal and metabolic disturbances,fore, these potential confounders could not be consid-
ered in this analysis. or through improved dietary intake and nutritional sta-
tus. In the absence of controlled data on pediatric out-The youngest patients, those younger than 24 months
at the time of dialysis initiation, have the lowest trans- comes, the National Kidney Foundation recently recom-
mended that the HD dose for children should be atplantation rates among children. These patients made
up 16% of the incident dialysis patients and only 11% least that recommended for adults [7]. However, some
pediatric centers are using substantially greater doses inof transplant recipients within this cohort. This may be
related to associated co-morbidities and small body size, children [13]. A NAPRTCS retrospective cohort study
is currently underway to evaluate current dosing prac-which preclude early renal transplantation among many
of these youngest patients (abstract; Wood EG, J Am tices and to address the impact of dialysis dose on growth
and nutritional status.Soc Nephrol 8:A0992, 1997).
These data showed that there are differences in the The mortality rates described here are substantially
lower than reported for adults [4]. Mortality rates amongweekly HD treatment frequency according to patient
age. The more frequent HD treatments in the youngest children were greatest among the youngest patients,
which may be related to associated congenital comorbid-children may have been related to their proportionately
greater fluid intake required to achieve adequate nutri- ities (abstract; Wood; ibid). Adjusted analyses of mortal-
ity rates and comparison with transplantation suggest thetion, and possibly to less consistent HD blood flow rates.
In addition, some centers may advocate frequent dialysis greatest mortality rates occur among children not con-
sidered candidates for transplantation (abstract: Leonardin an attempt to optimize growth and development in
the youngest children. The impact of dialysis adequacy MB, Transplantation 67:S125, 1999).
Finally, the recent release of the 2000 ESRD Clinicaland frequency on clinical outcomes is not known.
The frequent use of subclavian HD catheter access Performance Measures (CPM) Project in adolescents
treated with in-center HD [5] provides an opportunityreported in these children and adolescents is not consis-
tent with the National Kidney Foundation K/DOQI rec- to compare the management of adolescents treated at
ommendations [11]. The K/DOQI guidelines state that NAPRTCS centers with those treated nationwide. How-
the preferred insertion site for tunneled cuffed venous ever, the data presented in our NAPRTCS study demon-
dialysis catheters is the right internal jugular vein. The strate that patient characteristics change markedly over
subclavian should be used only when jugular options are time following dialysis initiation. Therefore, it is difficult
not available. to compare a cross-sectional population of children on
The NAPRTCS registry does not collect information HD after a mean duration of 2.9 years (median 1.3 years)
on blood pressure measurements, or on the types and with an incident cohort. Nonetheless, hemodialysis ac-
doses of antihypertensive medications. Further studies, cess characteristics and the prevalence of anemia in the
incorporating blood pressure, medication doses, under- CPM subjects were very similar to those observed at
lying renal disease and patient characteristics are neces- six months following HD initiation in the NAPRTCS
sary to assess the impact of dialysis on the control of cohort.
hypertension. In summary, the NAPRTCS registry now has exten-
NAPRTCS does not collect data on iron stores; there- sive data on a cohort of incident dialysis patients. These
fore, it is not possible to examine indications for iron data demonstrate substantial variability in patient man-
therapy in these patients. However, the prevalence of agement across pediatric nephrology centers in North
anemia reported here is comparable to that reported in America. Prospective studies are needed to determine
adults: the USRDS Dialysis Morbidity and Mortality the adequacy of care among children on dialysis, in terms
Study (wave 1) reported a mean Hct among adults on of the optimal timing of dialysis initiation, adequate con-
dialysis of 30.2%, with 43% having a Hct 30% [4]. trol of blood pressure, renal osteodystrophy and anemia,
Moreover, more than 50% of these adult patients were and access to transplantation. In addition, studies are
iron deficient. Therefore, there is likely room to improve indicated to identify populations at risk of receiving less
iron status in children, particularly among those on PD optimal care.
who rarely receive intravenous iron. The observation
Reprint requests to Mary B. Leonard, M.D., CHOP North Roomthat EPO dosing, expressed as units per kg per week, is
1564, The Children’s Hospital of Philadelphia, 34th Street and Civic
higher in HD patients than PD patients is consistent with Center Blvd., Philadelphia, Pennsylvania.
E-mail: leonard@email.chop.edustudies in adults [12].
Numerous outcome studies in adults have demon-
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